Compare Moderna, Inc. (MRNA) vs Ferrari NV (RACE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Ferrari NV — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Ferrari NV trades at $367.23 (market cap $65.48B). The key difference: Ferrari NV is far larger — about 2.8× Moderna, Inc.'s market cap, and Ferrari NV pays a 1.14% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | RACE | |
|---|---|---|
Market Cap | $23.60B | $65.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $517.65 |
52-Week Low | $22.36 | $314.63 |
Enterprise Value | $19.70B | $66.69B |
Dividend Yield | — | 1.14% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Ferrari NV
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →
